Skip to content
← Full study record

NCT01919086 · MORE INFO

Limitations, agreements, and source contact

Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma · Source last updated 2026-03-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
hassounh@mskcc.org
organization
Memorial Sloan Kettering Cancer Center
phone
646-608-3718
title
Dr. Hani Hassoun, MD
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
hassounh@mskcc.org
organization
Memorial Sloan Kettering Cancer Center
phone
646-608-3718
title
Dr. Hani Hassoun, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice